Effects of weight reduction with orlistat on cardiovascular risk in obese hyertensive patients with type 2 diabetes

被引：0
|
作者：
Uehara, MH [1 ]
Peres, RB [1 ]
Ferreira, SRG [1 ]
Zanella, MT [1 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
来源：
HYPERTENSION | 2001年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1042 / 1042
页数：1
相关论文
共 50 条
  • [41] Efficacy of orlistat in overweight and obese chinese patients with newly diagnosed type 2 diabetes
    Shi, YF
    DIABETES, 2003, 52 : A557 - A557
  • [42] Improvement of Insulin Resistance and Reduction of Cardiovascular Risk Among Obese Patients with Type 2 Diabetes with the Duodenojejunal Bypass Liner
    Hourneaux de Moura, Eduardo Guimaraes
    Bonotto Orso, Ivan Roberto
    Martins, Bruno da Costa
    Lopes, Guilherme Sauniti
    de Oliveira, Suzana Lopes
    Galvao-Neto, Manoel dos Passos
    Mancini, Marcio Correa
    Santo, Marco Aurelio
    Sakai, Paulo
    Ramos, Almino Cardoso
    Garrido-Junior, Arthur Belarmino
    Halpern, Alfredo
    Cecconello, Ivan
    OBESITY SURGERY, 2011, 21 (07) : 941 - 947
  • [43] Improvement of Insulin Resistance and Reduction of Cardiovascular Risk Among Obese Patients with Type 2 Diabetes with the Duodenojejunal Bypass Liner
    Eduardo Guimarães Hourneaux de Moura
    Ivan Roberto Bonotto Orso
    Bruno da Costa Martins
    Guilherme Sauniti Lopes
    Suzana Lopes de Oliveira
    Manoel dos Passos Galvão-Neto
    Marcio Correa Mancini
    Marco Aurélio Santo
    Paulo Sakai
    Almino Cardoso Ramos
    Arthur Belarmino Garrido-Júnior
    Alfredo Halpern
    Ivan Cecconello
    Obesity Surgery, 2011, 21 : 941 - 947
  • [44] Weight loss surgery and cardiovascular risk and mortality in patients with type 2 diabetes
    Pournaras, Dimitri J.
    Welbourn, Richard
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (11): : 828 - 829
  • [45] CARDIOVASCULAR EFFECTS OF WEIGHT REDUCTION IN OBESE PATIENTS WITH ANGINA-PECTORIS
    SHARMA, B
    THADANI, U
    TAYLOR, SH
    BRITISH HEART JOURNAL, 1974, 36 (09): : 854 - 858
  • [46] Orlistat efficacy on weight loss in over-weight or obese patients with type 2 diabetes mellitus. Spanish randomized clinical trial
    Serrano-Rios, M
    Armero, F
    Genis, M
    DIABETES, 2001, 50 : A131 - A131
  • [47] Cardiovascular risk reduction with orlistat therapy in overweight hypertensive patients
    Zanella, MT
    Bertolami, M
    JOURNAL OF HYPERTENSION, 2004, 22 : S88 - S88
  • [48] Interview Cardiovascular Risk Reduction for Type 2 Diabetes
    Leitner, H.
    JOURNAL FUR KARDIOLOGIE, 2019, 26 (3-4): : 92 - 94
  • [49] Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes
    Skelley, Jessica W.
    Carter, Brooke S.
    Roberts, Megan Z.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2018, 14 : 419 - 428
  • [50] Cardiovascular Risk Reduction in Type 2 Diabetes: Further Insights into the Power of Weight Loss and Exercise
    Lee, Seung-Hwan
    ENDOCRINOLOGY AND METABOLISM, 2023, 38 (03) : 302 - 304
12345